Acerca de Rising Tide Foundation for Clinical Cancer Research
Rising Tide Foundation for Clinical Cancer Research funds investigator-led clinical cancer research that is practical, patient-centered, and designed to improve outcomes or reduce burden in real-world care. Their programs emphasize interventional trials, therapy optimization, treatment resistance, early detection/recurrence, and supportive care, with a strong recurring commitment to patient partner involvement and international collaboration. They also support enabling infrastructure and small pre-application grants that help patient organizations and research teams co-develop stronger proposals.
Áreas de Enfoque
Clinical Cancer TrialsTherapy Optimization and Treatment ResistanceSupportive OncologyPediatric Blood CancersLung Cancer Recurrence and ResistancePatient Involvement Infrastructure
Enfoque de Donación
Primarily programmatic, competitive grants and joint calls, often via LOI and full-proposal review; awards range from small pre-application supports (~$4,000) to larger multi-year trial grants up to $1M, with some programs covering a set share of project costs rather than full funding. Funding is worldwide and tends to be targeted to specific clinical research calls, sometimes with rolling or periodic cutoff deadlines.
Cómo acercarte a este financiador
¿Quieres un Pitch Personalizado para Rising Tide Foundation for Clinical Cancer Research?
Regístrate gratis para ver qué tan bien se adapta tu organización sin fines de lucro a este financiador, obtener un pitch generado por IA y descubrir fundaciones similares.
Inteligencia semanal sobre subvenciones para líderes de impacto social. Oportunidades seleccionadas, tendencias de financiamiento e ideas estratégicas — gratis.
Únete a más de 500 líderes de impacto social. Cancela tu suscripción cuando quieras. Política de privacidad
De confianza para equipos con misión social en organizaciones de todo el país
Monitor their program-specific calls closely: many opportunities require an LOI first and then a full proposal, submitted through the SmartSimple portal or the relevant call process. Competitive trials should clearly show clinical relevance, patient partner involvement, scalability, and a strong plan to improve access, reduce toxicity, or address resistance/recurrence; for some awards, applicants should be prepared to cost-share because RTFCCR may fund only a portion of total project costs.
Beneficiarios destacados:
• LUNGevity Foundation
• Anticancer Fund
• Cancer patient organizations participating in the Match-making Service RFP
Oportunidades de Subvenciones Abiertas
Financiamiento actual y próximo de Rising Tide Foundation for Clinical Cancer Research al que tu organización sin fines de lucro podría postularse.
Abierta ahoraCierra en 27 días (22 jun 2026)
Open Call (RTFCCR Clinical Cancer Research LOIs)
Therapy OptimizationDisease and Treatment BurdenScience of Early Detection+2 más
¿Quién puede postularse? Interventional clinical trials (Phase I–III) with patient partner involvement; only institutions where effective grant oversight is feasible; co‑funding expected (RTFCCR typically does not cover total cost).
Fecha límite: LOIs accepted on a rolling basis with three annual cutoff deadlines (next listed deadlines: 22 June 2026 and 23 November 2026).
Abierta ahoraRecepción continua / abiertaMonto: Hasta 4 mil US$
Pre-application Grants (RTFCCR)
Patient partner involvementCapacity building for grant development
¿Quién puede postularse? Patient organisations or patient partners assisting in development of an RTFCCR grant application; project must be at pre-protocol development stage.
Fecha límite: Not specified; described as available to support pre-application activities (rolling availability implied).
Clinical cancer researchPredictive informationTreatment strategy optimization+1 más
¿Quién puede postularse? Academic-led clinical research projects that use predictive information to improve patient survival. Must include institutional co-funding.
Therapy OptimizationDisease and Treatment BurdenScience of Early Detection+2 más
¿Quién puede postularse? Accepts academic institutions and not-for-profit organizations for innovative, patient-centered interventional clinical trials. Projects should align with RTFCCR focus areas, involve patient partners, and typically require co-funding. The foundation does not fund basic research, phase IV trials, or observational studies.
Fecha límite: LOIs accepted all year round; internal assessment deadlines occur three times per year.
Abierta ahoraRecepción continua / abiertaMonto: Hasta 4 mil US$
Pre-application Grants
Patient involvement in clinical trial designClinical cancer research
¿Quién puede postularse? For projects at the pre-protocol development stage that need patient partner input to shape a grant application/protocol for submission to RTFCCR. Intended for patient organizations or teams working with patient partners on clinical trial development.
Supportive carePalliative oncologyQuality of life+2 más
¿Quién puede postularse? Applicants must be in their first to third year of a full-time, primary faculty appointment at an academic medical institution worldwide and secure an institutional mentor. Proposals must involve active patient partner participation and measurable outcomes.
Fecha límite: Program editions run annually; 2026/2027 edition opens from June 2026. Specific 2025/2026 deadlines listed as LOI due 2025-10-30 and full application due 2026-03-06.
Las fechas límite y los requisitos de elegibilidad son un resumen de fuentes públicas y pueden cambiar — confirma siempre los detalles en la página oficial de solicitud del financiador antes de postularte.